SCREEN for Type 1 Diabetes Act of 2024
Latest Action
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The SCREEN for Type 1 Diabetes Act of 2024 is a Senate bill introduced in the 118th Congress aimed at addressing Type 1 diabetes through screening initiatives. The bill was read twice and referred to the Committee on Health, Education, Labor, and Pensions but ultimately failed or expired without further legislative action. Specific details about the bill's provisions, funding, or implementation strategies are not available in the provided source data.
This bill sought to promote screening for Type 1 diabetes but did not advance beyond committee referral and expired without enactment.
- The bill focuses on Type 1 diabetes screening as a health policy area.
- It was introduced in the Senate during the 118th Congress and referred to the Health, Education, Labor, and Pensions Committee.
- No detailed summary or full text is available, limiting insight into specific provisions or mechanisms.
['Individuals at risk for or living with Type 1 diabetes who might benefit from early screening.', 'Healthcare providers involved in diabetes diagnosis and management.', 'Public health agencies focused on chronic disease prevention and management.']
['Lack of available full text and summary limits understanding of cost implications and funding sources.', 'Unclear authority and oversight mechanisms due to missing legislative details.', 'Implementation challenges cannot be assessed without specific programmatic details.']
The bill was introduced in the Senate and referred to the Committee on Health, Education, Labor, and Pensions during the 118th Congress but did not progress further, resulting in its failure or expiration. This reflects the legislative process where many bills do not advance beyond committee referral.
Hidden impact flags detected: 1
GovScope reviewed 1 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['If enacted, the bill could have led to increased early detection of Type 1 diabetes, potentially reducing long-term health complications and associated healthcare costs.', 'Screening initiatives might have influenced public health priorities and resource allocation toward chronic disease prevention.']
The absence of a bill summary and full text in the official source data highlights a transparency gap that limits comprehensive public and stakeholder analysis. Monitoring such gaps is important to ensure informed legislative oversight and public engagement.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.